Home » Topics » BioWorld Science

BioWorld Science
RSS

Getting, and keeping, antitumor T cells energized

Dec. 19, 2019

ALDH2 and Alzheimer's

Dec. 19, 2019

First data presented for XmAb-13676 in refractory/relapsed NHL and CLL

Dec. 19, 2019

MEDS-433 demonstrates promising antileukemic activity and limited toxicity in vivo

Dec. 19, 2019

Sangamo Therapeutics presents preliminary data from phase I/II study of ST-400

Dec. 19, 2019

CXCL10 arises as a potential therapeutic target for treating motor neuron disease

Dec. 19, 2019

Proteostasis reports phase II topline data on CFTR modulator combinations in cystic fibrosis

Dec. 18, 2019

BioInvent and MSD enter clinical trial collaboration to study BI-1206 with Keytruda in solid tumors

Dec. 18, 2019

Nordic Nanovector receives funding to support Alpha37 program

Dec. 18, 2019

Phase Ib data on PXL-065 support progression to phase II for NASH

Dec. 18, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
Nankai University and Accendatech present new majusculamide D derivatives
BioWorld Science
Scientists from Nankai University Tianjin and Accendatech Technology Co. Ltd. have identified a majusculamide D derivative found to be useful for the treatment of...